<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Ciclopirox: Pediatric drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Ciclopirox: Pediatric drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Ciclopirox: Pediatric drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_general" data-topicid="9263" href="/d/html/9263.html" rel="external">see "Ciclopirox: Drug information"</a> and <a class="drug drug_patient" data-topicid="12146" href="/d/html/12146.html" rel="external">see "Ciclopirox: Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F151212"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Ciclodan;</li>
<li>Ciclopirox Treatment;</li>
<li>Loprox [DSC];</li>
<li>Penlac [DSC]</li></ul></div>
<div class="list canbnlist drugH1Div drugBrandNames" id="F52866330"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>APO-Ciclopirox;</li>
<li>Loprox;</li>
<li>Penlac Nail Lacquer;</li>
<li>Stieprox;</li>
<li>TARO-Ciclopirox</li></ul></div>
<div class="list_set htclist drugH1Div drugBrandNames" id="F1005707"><span class="drugH1">Therapeutic Category</span>
<ul>
<li>
<span class="list-set-name">Antifungal Agent, Topical</span></li></ul></div>
<div class="block dop drugH1Div" id="F151228"><span class="drugH1">Dosing: Pediatric</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="46f7e92c-16a7-4ba0-a656-314e572728cb">Cutaneous candidiasis, tinea cruris, and tinea versicolor</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Cutaneous candidiasis, tinea cruris, and tinea versicolor (pityriasis versicolor):</b> Cream and suspension (lotion): Children ≥10 years and Adolescents: Topical: Apply twice daily (morning and evening) to the affected area; if no improvement after 4 weeks, reevaluate treatment</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="8bdaf091-5a54-470d-baa9-3dcfbb193c1a">Tinea corporis, tinea pedis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Tinea corporis, tinea pedis: </b></p>
<p style="text-indent:-2em;margin-left:4em;">Cream and suspension (lotion): Children ≥10 years and Adolescents: Topical: Apply twice daily (morning and evening) to the affected area; if no improvement after 4 weeks, reevaluate treatment</p>
<p style="text-indent:-2em;margin-left:4em;">Gel: Adolescents ≥16 years: Topical: Apply twice daily (morning and evening) to affected areas and surrounding skin; if no improvement after 4 weeks of treatment, reevaluate diagnosis</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="4bcbf412-68fb-4b1d-bdd0-80ed6e8b00cc">Onychomycosis of the fingernails and toenails</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Onychomycosis of the fingernails and toenails:</b> Lacquer (solution): Children ≥12 years and Adolescents: Topical: Apply to adjacent skin and affected nails once daily preferably at bedtime or 8 hours before washing (as a part of a comprehensive management program for onychomycosis). Remove with alcohol every 7 days.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="5b2f1229-5d46-48b6-9dce-b46d78b49425">Seborrheic dermatitis of the scalp</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Seborrheic dermatitis of the scalp:</b> Adolescents ≥16 years: Topical:</p>
<p style="text-indent:-2em;margin-left:4em;">Gel: Apply twice daily, gently massage into affected areas and surrounding skin; if no improvement after 4 weeks of treatment, reevaluate diagnosis</p>
<p style="text-indent:-2em;margin-left:4em;">Shampoo: Apply ~5 mL to wet hair; lather, and leave in place ~3 minutes; rinse. May use up to 10 mL for longer hair. Repeat twice weekly for 4 weeks; allow a minimum of 3 days between applications; if no improvement after 4 weeks of treatment, reevaluate diagnosis</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51084773"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block dohp drugH1Div" id="F51084774"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doa drugH1Div" id="F151215"><span class="drugH1">Dosing: Adult</span><p>(For additional information <a class="drug drug_general" data-topicid="9263" href="/d/html/9263.html" rel="external">see "Ciclopirox: Drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="6ced5dbd-c9d4-4c44-b186-0063d11e58e2">Cutaneous candidiasis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Cutaneous candidiasis:</b>
<b>Topical:</b> Cream 0.77%, suspension 0.77%: Apply twice daily, gently massage into affected areas and surrounding skin; if no improvement after 4 weeks of treatment, re-evaluate the diagnosis.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="c8f07d0e-f993-43db-b958-cdaa7029798f">Onychomycosis, mild to moderate</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Onychomycosis, mild to moderate:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note: </b>For patients with distal subungual onychomycosis involving ≤50% of the nail and sparing the matrix/lunula (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Goldstein.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Goldstein.2'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Topical:</b> Lacquer (solution): Apply to affected fingernail(s) and/or toenail(s) and adjacent skin once daily in combination with weekly nail trimming and periodic nail debridement. Remove with alcohol every 7 days; continue therapy until nail clearance (maximum duration: 48 weeks) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-11051136','lexi-content-ref-Manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-11051136','lexi-content-ref-Manu.1'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="5b2f1229-5d46-48b6-9dce-b46d78b49425">Seborrheic dermatitis of the scalp</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Seborrheic dermatitis of the scalp: Topical:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Gel 0.77%: Apply twice daily, gently massage into affected area; if no improvement after 4 weeks of treatment, re-evaluate diagnosis.</p>
<p style="text-indent:-2em;margin-left:4em;">Shampoo 1%: Apply ~5 mL to wet hair; lather, and leave on hair and scalp for ~3 minutes; rinse. May use up to 10 mL for longer hair. Repeat twice weekly for 4 weeks; allow a minimum of 3 days between applications; if no improvement after 4 weeks of treatment, re-evaluate diagnosis.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="15c0a5bc-b04b-4bce-808a-eba28afcd673">Tinea infections</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Tinea infections:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Tinea corporis/tinea cruris:</i>
<b>Topical:</b> Cream 0.77%, gel 0.77% (gel is for tinea corporis only), lotion 1% [Canadian product], suspension 0.77%: Apply to affected and surrounding area(s) twice daily until clinical resolution, typically 1 to 4 weeks (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Goldstein.1','lexi-content-ref-25294700','lexi-content-ref-Manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Goldstein.1','lexi-content-ref-25294700','lexi-content-ref-Manu.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Tinea pedis (labeled use)/tinea manuum (off-</i>
<i>label use):</i>
<b>Topical:</b> Cream 0.77%, gel 0.77%, lotion 1% [Canadian product], suspension 0.77%: Apply to affected and surrounding area(s) once or twice daily until 1 week after clinical resolution, typically for 4 weeks total (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Goldstein.1','lexi-content-ref-15985032','lexi-content-ref-12046779','lexi-content-ref-Manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Goldstein.1','lexi-content-ref-15985032','lexi-content-ref-12046779','lexi-content-ref-Manu.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Tinea versicolor (pityriasis versicolor):</i>
<b>Topical:</b> Cream 0.77%, suspension 0.77%: Apply to affected area(s) and immediate surrounding skin twice daily for 2 weeks (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-2865009','lexi-content-ref-Manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-2865009','lexi-content-ref-Manu.1'])">Ref</a></span>).</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50991112"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling. </p></div>
<div class="block doha drugH1Div" id="F50988421"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling. </p></div>
<div class="block adr drugH1Div" id="F151189"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;">&gt;10%: Local: Application-site reaction (including application-site burning [≤34%], application-site erythema [1%], application-site irritation, application-site pain [&lt;1%], application-site pruritus [≤5%])</p>
<p style="text-indent:-2em;margin-left:2em;">1% to 10%: Dermatologic: Contact dermatitis (gel: 1% to 5%), erythematous condition (solution: erythema of proximal nail fold [≤5%], periungual erythema [≤5%]), pruritus (1% to 5%)</p>
<p style="text-indent:-2em;margin-left:2em;">&lt;1%:</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Acne vulgaris (gel), alopecia (gel, shampoo), skin rash (gel, shampoo), xeroderma (gel)</p>
<p style="text-indent:-2em;margin-left:4em;">Hypersensitivity: Facial edema (gel)</p>
<p style="text-indent:-2em;margin-left:4em;">Ophthalmic: Eye pain (gel)</p>
<p style="text-indent:-2em;margin-left:2em;">Frequency not defined: Dermatologic: Changes in nails (solution: shape), nail discoloration (solution)</p>
<p style="text-indent:-2em;margin-left:2em;">Postmarketing: Dermatologic: Abnormal hair texture (shampoo), hair discoloration (shampoo)</p></div>
<div class="block coi drugH1Div" id="F151200"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Hypersensitivity to ciclopirox or any component of the formulation</p></div>
<div class="block war drugH1Div" id="F151186"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Irritation: Discontinue if sensitivity or irritation occurs and institute appropriate therapy.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Special populations:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Immunocompromised patients: Use with caution; use has not been evaluated in immunosuppressed or immunocompromised patients.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Dosage form specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Benzyl alcohol and derivatives: Some dosage forms may contain benzyl alcohol; large amounts of benzyl alcohol (≥99 mg/kg/day) have been associated with a potentially fatal toxicity ("gasping syndrome") in neonates; the "gasping syndrome" consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension and cardiovascular collapse (AAP ["Inactive" 1997]; CDC 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol with caution in neonates. See manufacturer’s labeling.</p>
<p style="text-indent:-2em;margin-left:4em;">• Nail lacquer: For topical use only; has not been studied in conjunction with systemic therapy or in patients with type 1 diabetes mellitus (insulin dependent, IDDM) or diabetic neuropathy.</p>
<p style="text-indent:-2em;margin-left:4em;">• Shampoo: Patients with lighter hair color may experience hair discoloration.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions: </i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use: For topical use only; avoid contact with eyes or mucous membranes. Use of occlusive dressings or wrappings should be avoided.</p></div>
<div class="block add-pediatric-warn-info drugH1Div" id="F52878383"><span class="drugH1">Warnings: Additional Pediatric Considerations</span>
<p style="text-indent:0em;display:inline">Some dosage forms may contain propylene glycol; in neonates large amounts of propylene glycol delivered orally, intravenously (eg, &gt;3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures and respiratory depression; use caution (AAP 1997; Shehab 2009).</p></div>
<div class="block foc drugH1Div" id="F151195"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Cream, External, as olamine [strength expressed as base]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Loprox: 0.77% (90 g [DSC]) [contains benzyl alcohol, cetyl alcohol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.77% (15 g, 30 g, 90 g)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Gel, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.77% (30 g, 45 g, 100 g)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Kit, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ciclopirox Treatment: 8% [contains edetate (edta) disodium, isopropyl alcohol, menthol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Loprox: 0.77% [DSC] [contains benzyl alcohol, cetyl alcohol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Loprox: 0.77% [DSC] [contains benzyl alcohol, cetyl alcohol, edetate (edta) disodium, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Shampoo, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Loprox: 1% (120 mL [DSC])</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 1% (120 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ciclodan: 8% (6.6 mL) [contains isopropyl alcohol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Penlac: 8% (6.6 mL [DSC]) [contains ethyl acetate, isopropyl alcohol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 8% (6.6 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Suspension, External, as olamine [strength expressed as base]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Loprox: 0.77% (60 mL [DSC]) [contains benzyl alcohol, cetyl alcohol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.77% (30 mL, 60 mL)</p></div>
<div class="block geq drugH1Div" id="F151182"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F151201"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Cream</b> (Ciclopirox Olamine External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.77% (per gram): $1.70 - $2.93</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Gel</b> (Ciclopirox External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.77% (per gram): $2.69 - $3.37</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Shampoo</b> (Ciclopirox External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per mL): $0.78 - $1.23</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Ciclodan External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">8% (per mL): $88.32</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Ciclopirox External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">8% (per mL): $8.02 - $27.12</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Suspension</b> (Ciclopirox Olamine External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.77% (per mL): $1.62 - $2.43</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block dinfoc drugH1Div" id="F52866331"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Cream, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Loprox: 1% (45 g) [contains benzyl alcohol, cetyl alcohol]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Lotion, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Loprox: 1% (60 mL) [contains benzyl alcohol, cetyl alcohol]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Shampoo, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Stieprox: 1.5% (150 mL) [contains polysorbate 80]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Penlac Nail Lacquer: 8% (3 g, 6 g, 12 g) [contains ethyl acetate, isopropyl alcohol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 8% (6 g)</p></div>
<div class="block admp drugH1Div" id="F52612417"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Topical: For topical use only; not for ophthalmic, oral, or intravaginal use.</p>
<p style="text-indent:-2em;margin-left:2em;">Cream, gel, suspension (lotion): Gently massage into affected areas and surrounding skin in the morning and evening. Avoid contact with eyes and mucous membranes; do not administer orally or intravaginally. Do not occlude affected area with dressings or wrappings. Shake suspension (lotion) vigorously before application.</p>
<p style="text-indent:-2em;margin-left:2em;">Shampoo: Apply to wet hair and scalp, lather, and leave in place ~3 minutes; rinse thoroughly. Avoid contact with eyes.</p>
<p style="text-indent:-2em;margin-left:2em;">Solution (lacquer): Apply evenly over the entire nail plate and 5 mm of surrounding skin using the applicator brush; allow to dry for 30 seconds; apply at bedtime (or allow 8 hours before washing). Solution can be reapplied daily over previous applications; remove with alcohol every 7 days. After ciclopirox is removed with alcohol, file away (with emery board) loose nail material and trim nails, as required or as directed by a health care professional. Avoid contact with eyes and mucous membranes; do not administer orally or intravaginally. Do not use nail polish or other nail cosmetic products on the treated nails.</p></div>
<div class="block adm drugH1Div" id="F151197"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">
<b>Topical:</b> For topical use only; not for ophthalmic, oral, or intravaginal use.</p>
<p style="text-indent:-2em;margin-left:2em;">Cream: Gently massage into affected areas and surrounding skin in the morning and evening.</p>
<p style="text-indent:-2em;margin-left:2em;">Gel: Gently massage into clean, affected areas or to scalp and adjacent skin in the morning and evening.</p>
<p style="text-indent:-2em;margin-left:2em;">Lacquer (solution): Apply evenly over nail (apply evenly over entire nail plate, and if possible to nail bed and under nail plate surface) and surrounding skin at bedtime (or allow 8 hours before washing); apply daily over previous coat for 7 days; after 7 days, may remove with alcohol and continue cycle. Every 7 days after ciclopirox is removed with alcohol, file away (with emery board) loose nail material and trim nails, as required or as directed by a health care professional.</p>
<p style="text-indent:-2em;margin-left:2em;">Shampoo: Wet hair and apply to the scalp; lather and leave on hair and scalp for ~3 minutes; rinse. Avoid contact with eyes.</p>
<p style="text-indent:-2em;margin-left:2em;">Suspension: Shake well before use; gently massage into affected areas and surrounding skin in the morning and evening.</p></div>
<div class="block sts drugH1Div" id="F151209"><span class="drugH1">Storage/Stability</span>
<p style="text-indent:-2em;margin-left:2em;">Cream, gel, shampoo: Store at 15°C to 30°C (59°F to 86°F).</p>
<p style="text-indent:-2em;margin-left:2em;">Nail lacquer (solution): Store at 15°C to 30°C (59°F to 86°F). Protect from light. Flammable; keep away from heat and flame.</p>
<p style="text-indent:-2em;margin-left:2em;">Suspension: Store at 5°C to 25°C (41°F to 77°F).</p></div>
<div class="block usep drugH1Div" id="F53566058"><span class="drugH1">Use</span>
<p style="text-indent:-2em;margin-left:2em;">Cream/suspension (lotion): Treatment of cutaneous candidiasis, tinea pedis, tinea cruris, tinea versicolor (pityriasis versicolor), and tinea corporis (FDA approved in ages ≥10 years and adults).</p>
<p style="text-indent:-2em;margin-left:2em;">Gel: Treatment of tinea corporis, interdigital tinea pedis, and treatment of seborrheic dermatitis of the scalp (FDA approved in ages ≥16 years and adults).</p>
<p style="text-indent:-2em;margin-left:2em;">Shampoo: Treatment of seborrheic dermatitis of the scalp (FDA approved in ages ≥16 years and adults).</p>
<p style="text-indent:-2em;margin-left:2em;">Solution (lacquer): Treatment of mild to moderate onychomycosis of fingernails and toenails (not involving the lunula) in immunocompetent patients (FDA approved in ages ≥12 years and adults).</p></div>
<div class="block cyt drugH1Div" id="F13299041"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F151190"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block pri drugH1Div" id="F151202"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;display:inline">Adverse events were not observed in animal reproduction studies. </p></div>
<div class="block mopp drugH1Div" id="F53566020"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Resolution of skin or nail infection</p></div>
<div class="block pha drugH1Div" id="F151185"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Inhibiting transport of essential elements in the fungal cell disrupting the synthesis of DNA, RNA, and protein</p></div>
<div class="block phk drugH1Div" id="F151199"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Absorption: Cream, suspension: 1.3% through intact skin; increased with gel; &lt;5% with lacquer</p>
<p style="text-indent:-2em;margin-left:2em;">Distribution: Scalp application: To epidermis, corium (dermis), including hair, hair follicles, and sebaceous glands</p>
<p style="text-indent:-2em;margin-left:2em;">Metabolism: Conjugated with glucuronic acid</p>
<p style="text-indent:-2em;margin-left:2em;">Half-life elimination: Biologic: Cream, suspension: 1.7 hours; Elimination: Gel: 5.5 hours</p>
<p style="text-indent:-2em;margin-left:2em;">Excretion: Urine (Gel: 3% to 10%; Shampoo: &lt;0.5%; Cream, suspension: 0.01%); feces (small amounts)</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F151203"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AE)</span> <span class="country">United Arab Emirates</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Fisioativ | Mycoster</span>;</li>
<li>
<span class="countryCode">(AR)</span> <span class="country">Argentina</span><span class="countrySeparator">: </span><span class="drugName">Dermaflor | Loprox | Micomazol laca | Micopirox | Mycosten | Mycosten 8% Laca | Niogermox | Stieprox | Stiprox</span>;</li>
<li>
<span class="countryCode">(AT)</span> <span class="country">Austria</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Ciclocutan | Kitonail | Stieprox</span>;</li>
<li>
<span class="countryCode">(AU)</span> <span class="country">Australia</span><span class="countrySeparator">: </span><span class="drugName">Rejuvenail anti fungal | Stieprox</span>;</li>
<li>
<span class="countryCode">(BD)</span> <span class="country">Bangladesh</span><span class="countrySeparator">: </span><span class="drugName">Candela | Candirox | Cicloderm | Clopirox</span>;</li>
<li>
<span class="countryCode">(BE)</span> <span class="country">Belgium</span><span class="countrySeparator">: </span><span class="drugName">Myconail | Mycosten</span>;</li>
<li>
<span class="countryCode">(BF)</span> <span class="country">Burkina Faso</span><span class="countrySeparator">: </span><span class="drugName">Mycorex | Mycoster</span>;</li>
<li>
<span class="countryCode">(BG)</span> <span class="country">Bulgaria</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Dafnegin | Polinail</span>;</li>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Ciclopirox olamina | Fungirox | Gino-loprox | Loprox | Micolamina | Micoliv | Stiprox</span>;</li>
<li>
<span class="countryCode">(CH)</span> <span class="country">Switzerland</span><span class="countrySeparator">: </span><span class="drugName">Ciclopoli | Dafnegil | Dafnegil neo | Mycoster</span>;</li>
<li>
<span class="countryCode">(CL)</span> <span class="country">Chile</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Fungopirox | Micopirox | Mikium | Privex laca para | Stiprox | Tigel cx</span>;</li>
<li>
<span class="countryCode">(CN)</span> <span class="country">China</span><span class="countrySeparator">: </span><span class="drugName">Batrafen n.l | Huan li</span>;</li>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Mycoster | Niogermox | Primax | Stiprox</span>;</li>
<li>
<span class="countryCode">(CZ)</span> <span class="country">Czech Republic</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Dafnegin | Polinail</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Ciclocutan | Ciclopirox acis | Ciclopirox adgc | Ciclopirox beta | Ciclopirox dermapharm | Ciclopirox Hexal | Ciclopirox Winthrop | Ciclopoli | Ciclotau | Hauticum | Inimur myko | Miclast | Mycoster | Nagel batrafen | Selergo</span>;</li>
<li>
<span class="countryCode">(DO)</span> <span class="country">Dominican Republic</span><span class="countrySeparator">: </span><span class="drugName">Brumixol | Fungowas | Gidacid | Loprox</span>;</li>
<li>
<span class="countryCode">(EC)</span> <span class="country">Ecuador</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Ony tec | Stiprox</span>;</li>
<li>
<span class="countryCode">(EE)</span> <span class="country">Estonia</span><span class="countrySeparator">: </span><span class="drugName">Mycofen | Onytec</span>;</li>
<li>
<span class="countryCode">(EG)</span> <span class="country">Egypt</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Mycoster | Notriprox | Tineapirox</span>;</li>
<li>
<span class="countryCode">(ES)</span> <span class="country">Spain</span><span class="countrySeparator">: </span><span class="drugName">Ciclochem | Ciclocutan | Ciclonic | Ciclonutrax | Ciclopirox isdin | Ciclopirox olamina abamed | Ciclopirox olamina capitec | Ciclopirox Olamina Serra | Ciclopirox serra | Cicloseb | Dexulac | Fungowas | Kitonail | Miclast | Ony tec | Sebiprox</span>;</li>
<li>
<span class="countryCode">(FI)</span> <span class="country">Finland</span><span class="countrySeparator">: </span><span class="drugName">Onytec | Stieprox</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">Ciclopirox biogaran | Ciclopirox mylan | Ciclopirox olamine arrow | Ciclopirox olamine Biogaran | Ciclopirox olamine mylan | Ciclopirox olamine Pierre Fabre | Ciclopirox olamine sandoz | Ciclopirox olamine teva | Ciclopirox olamine viatris | Ciclopirox qualimed | Ciclopirox ratiopharm | Ciclopiroxolam olamine gerda | Myconail | Mycoskin | Mycoster | Onytec | Sebiprox</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Oilatum anti dandruff</span>;</li>
<li>
<span class="countryCode">(GR)</span> <span class="country">Greece</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Candimyk | Dafnegin | Kitonail | Mycolacil | Mycomycen | Neo botacreme | Neo mycodermol | Stieprox</span>;</li>
<li>
<span class="countryCode">(HK)</span> <span class="country">Hong Kong</span><span class="countrySeparator">: </span><span class="drugName">Apo-Ciclopirox | Batrafen | Stieprox</span>;</li>
<li>
<span class="countryCode">(HR)</span> <span class="country">Croatia</span><span class="countrySeparator">: </span><span class="drugName">Oxolam</span>;</li>
<li>
<span class="countryCode">(HU)</span> <span class="country">Hungary</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Kitolak | Kitonail</span>;</li>
<li>
<span class="countryCode">(ID)</span> <span class="country">Indonesia</span><span class="countrySeparator">: </span><span class="drugName">Batrafen</span>;</li>
<li>
<span class="countryCode">(IE)</span> <span class="country">Ireland</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Stieprox</span>;</li>
<li>
<span class="countryCode">(IL)</span> <span class="country">Israel</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Cicloderm</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">8x | Batrafen | C win | Candidox | Cinatop | Civaderm | Nailon | Nailrox | Olamin | Tojar | Trifas | Triogel</span>;</li>
<li>
<span class="countryCode">(IT)</span> <span class="country">Italy</span><span class="countrySeparator">: </span><span class="drugName">Batracomb | Batrafen | Batrafen unghie | Brumixol | Dafnegin | Miclast | Micomicen | Micoxolamina | Niogermox | Polinail | Roxolac | Sebiprox</span>;</li>
<li>
<span class="countryCode">(JO)</span> <span class="country">Jordan</span><span class="countrySeparator">: </span><span class="drugName">Mycoster | Stieprox</span>;</li>
<li>
<span class="countryCode">(JP)</span> <span class="country">Japan</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Lamaston</span>;</li>
<li>
<span class="countryCode">(KE)</span> <span class="country">Kenya</span><span class="countrySeparator">: </span><span class="drugName">Onylac</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Airprox | Bargio | Carevid | Ciclo once | Cikroxol | Clox | Crocxol | Cyclo care | Dendpirox | Fulcare | K prox | Loprox | Momorox | Mujonal s | Muzome | Nailae | Nailstar | Newsilk | Nobiprox | Onecare | Pm | Sebiprox | Sebitop | Topcure | Troxi | Troxy | Varengood | Virox | Widecare | Yuhan easycare nail lacquer</span>;</li>
<li>
<span class="countryCode">(KW)</span> <span class="country">Kuwait</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Mycoster | Stieprox</span>;</li>
<li>
<span class="countryCode">(LB)</span> <span class="country">Lebanon</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Brumixol | Mycoskin | Mycoster | Stieprox</span>;</li>
<li>
<span class="countryCode">(LT)</span> <span class="country">Lithuania</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Ciclopoli | Kitonail | Onytec | Sebiprox | Stieprox</span>;</li>
<li>
<span class="countryCode">(LU)</span> <span class="country">Luxembourg</span><span class="countrySeparator">: </span><span class="drugName">Mycoster</span>;</li>
<li>
<span class="countryCode">(LV)</span> <span class="country">Latvia</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Cicloderm | Onytec | Sebiprox</span>;</li>
<li>
<span class="countryCode">(MA)</span> <span class="country">Morocco</span><span class="countrySeparator">: </span><span class="drugName">Mycoster | Sebiprox</span>;</li>
<li>
<span class="countryCode">(MX)</span> <span class="country">Mexico</span><span class="countrySeparator">: </span><span class="drugName">Bonnetril | Dermoster | Funamix | Loprox | Niogermox | Stiprox</span>;</li>
<li>
<span class="countryCode">(MY)</span> <span class="country">Malaysia</span><span class="countrySeparator">: </span><span class="drugName">Stieprox | Tolnaderm Ai</span>;</li>
<li>
<span class="countryCode">(NL)</span> <span class="country">Netherlands</span><span class="countrySeparator">: </span><span class="drugName">Ciclopiroxolamine ERC | Loprox</span>;</li>
<li>
<span class="countryCode">(NO)</span> <span class="country">Norway</span><span class="countrySeparator">: </span><span class="drugName">Onytec | Stieprox</span>;</li>
<li>
<span class="countryCode">(NZ)</span> <span class="country">New Zealand</span><span class="countrySeparator">: </span><span class="drugName">Apotex ciclopirox | Batrafen | Rejuvenail anti fungal | Stieprox</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Batralan | Fungopirox | Micopirox | Mycocid | Ony tec</span>;</li>
<li>
<span class="countryCode">(PH)</span> <span class="country">Philippines</span><span class="countrySeparator">: </span><span class="drugName">Stieprox</span>;</li>
<li>
<span class="countryCode">(PK)</span> <span class="country">Pakistan</span><span class="countrySeparator">: </span><span class="drugName">Stieprox</span>;</li>
<li>
<span class="countryCode">(PL)</span> <span class="country">Poland</span><span class="countrySeparator">: </span><span class="drugName">Axopirox | Batrafen | Dafnegin | Hascofungin | Pirolam | Polinail | Stieprox</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Ciclodan | Ciclopirox | Loprox | Penlac nail</span>;</li>
<li>
<span class="countryCode">(PT)</span> <span class="country">Portugal</span><span class="countrySeparator">: </span><span class="drugName">Mycoster | Niogermos | Sebiprox</span>;</li>
<li>
<span class="countryCode">(PY)</span> <span class="country">Paraguay</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Ciclopiroxolamina dutriec | Micopirox | Stiprox</span>;</li>
<li>
<span class="countryCode">(RO)</span> <span class="country">Romania</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Cicloderm | Dafnegin | Kitonail</span>;</li>
<li>
<span class="countryCode">(RU)</span> <span class="country">Russian Federation</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Cyclopoli | Dafnegin | Fonzhial</span>;</li>
<li>
<span class="countryCode">(SE)</span> <span class="country">Sweden</span><span class="countrySeparator">: </span><span class="drugName">Onytec | Sebiprox</span>;</li>
<li>
<span class="countryCode">(SG)</span> <span class="country">Singapore</span><span class="countrySeparator">: </span><span class="drugName">Stieprox</span>;</li>
<li>
<span class="countryCode">(SI)</span> <span class="country">Slovenia</span><span class="countrySeparator">: </span><span class="drugName">Onytec</span>;</li>
<li>
<span class="countryCode">(SK)</span> <span class="country">Slovakia</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Dafnegin | Polinail | Stieprox</span>;</li>
<li>
<span class="countryCode">(TH)</span> <span class="country">Thailand</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Clopirox | Loprox</span>;</li>
<li>
<span class="countryCode">(TN)</span> <span class="country">Tunisia</span><span class="countrySeparator">: </span><span class="drugName">Brumixol | Mycorex | Mycoster | Sebiprox</span>;</li>
<li>
<span class="countryCode">(TR)</span> <span class="country">Turkey</span><span class="countrySeparator">: </span><span class="drugName">Canolen | Nibulen | Opilox | Sebirox | Siroksil</span>;</li>
<li>
<span class="countryCode">(TW)</span> <span class="country">Taiwan</span><span class="countrySeparator">: </span><span class="drugName">Broax | Brumixol | Ciclom | Henoritle kangxie | Micoside | Opus | Silux | Sparkling | Stieprox | Sufoot</span>;</li>
<li>
<span class="countryCode">(UA)</span> <span class="country">Ukraine</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Ciclocutan</span>;</li>
<li>
<span class="countryCode">(UY)</span> <span class="country">Uruguay</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Batrafen Laca para Unas | Lacapirox | Micopirox | Stiprox</span>;</li>
<li>
<span class="countryCode">(VE)</span> <span class="country">Venezuela, Bolivarian Republic of</span><span class="countrySeparator">: </span><span class="drugName">Batrafen | Mycoster | Stiprox</span>;</li>
<li>
<span class="countryCode">(ZA)</span> <span class="country">South Africa</span><span class="countrySeparator">: </span><span class="drugName">Sebiprox | Stieprox</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-11487763">
<a name="11487763"></a>Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319. doi:10.1067/mpd.2001.116281<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/ciclopirox-pediatric-drug-information/abstract-text/11487763/pubmed" id="11487763" target="_blank">11487763</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Barber.1">
<a name="Barber.1"></a>Barber K, Claveau J, Thomas R. Review of Treatment for Onychomycosis: Consideration for Special Populations. <i>J Cutan Med Surg</i>. 2006;10(suppl 2):S48-S53. doi:10.2310/7750.2006.00054</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6810084">
<a name="6810084"></a>Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol—United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. <a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm" target="_blank">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a>
<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/ciclopirox-pediatric-drug-information/abstract-text/6810084/pubmed" id="6810084" target="_blank">6810084</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Ciclodan.2">
<a name="Ciclodan.2"></a>Ciclodan Cream (ciclopirox) [prescribing information]. Fairfield, NJ: Medimetriks pharmaceuticals Inc; January 2012.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Ciclodan.1">
<a name="Ciclodan.1"></a>Ciclodan Nail Lacquer Solution (ciclopirox) [prescribing information]. Fairfield, NJ: Medimetriks Pharmaceuticals Inc; March 2015.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Ciclopirox.2">
<a name="Ciclopirox.2"></a>Ciclopirox Gel [prescribing information]. Melville, NY: Fougera Pharmaceuticals Inc; October 2013.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Ciclopirox.1">
<a name="Ciclopirox.1"></a>Ciclopirox Suspension [prescribing information]. Melville, NY: Fougera Pharmaceutical Inc; August 2014.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-2865009">
<a name="2865009"></a>Cullen SI, Frost P, Jacobson C, et al. Treatment of tinea versicolor with a new antifungal agent, ciclopirox olamine cream 1%. <i>Clin Ther</i>. 1985;7(5):574-583.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/ciclopirox-pediatric-drug-information/abstract-text/2865009/pubmed" id="2865009" target="_blank">2865009</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15696982">
<a name="15696982"></a>Gallup E, Plott T; Ciclopirox TS Investigators. A Multicenter, Open-Label Study to Assess the Safety and Efficacy of Ciclopirox Topical Suspension 0.77% in the Treatment of Diaper Dermatitis Due to <i>Candida albicans</i>.<i> J Drugs Dermatol</i>. 2005;4(1):29-34.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/ciclopirox-pediatric-drug-information/abstract-text/15696982/pubmed" id="15696982" target="_blank">15696982</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Goldstein.2">
<a name="Goldstein.2"></a>Goldstein AO, Bhatia N. Onychomycosis: management. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed August 15, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Goldstein.1">
<a name="Goldstein.1"></a>Goldstein AO, Goldstein BG. Dermatophyte (tinea) infections. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed August 24, 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-18478357">
<a name="18478357"></a>Gupta AK, Cooper EA. Update in antifungal therapy of dermatophytosis. <i>Mycopathologia</i>. 2008;166(5-6):353-367. doi:10.1007/s11046-008-9109-0<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/ciclopirox-pediatric-drug-information/abstract-text/18478357/pubmed" id="18478357" target="_blank">18478357</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11051136">
<a name="11051136"></a>Gupta AK, Fleckman P, Baran R. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis. <i>J Am Acad Dermatol</i>. 2000;43(4)(suppl):S70-S80. doi:10.1067/mjd.2000.109071<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/ciclopirox-pediatric-drug-information/abstract-text/11051136/pubmed" id="11051136" target="_blank">11051136</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15985032">
<a name="15985032"></a>Gupta AK, Skinner AR, Cooper EA. Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial. <i>Int J Dermatol</i>. 2005;44(7):590-593. doi:10.1111/j.1365-4632.2004.02559.x<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/ciclopirox-pediatric-drug-information/abstract-text/15985032/pubmed" id="15985032" target="_blank">15985032</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9024461">
<a name="9024461"></a>"Inactive" ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics (AAP) Committee on Drugs. <i>Pediatrics</i>. 1997;99(2):268-278.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/ciclopirox-pediatric-drug-information/abstract-text/9024461/pubmed" id="9024461" target="_blank">9024461</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Loprox.3">
<a name="Loprox.3"></a>Loprox Cream (ciclopirox) [prescribing information]. Fairfield, NJ: Medimetriks Pharmaceuticals Inc; January 2016.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Loprox.2">
<a name="Loprox.2"></a>Loprox Shampoo (ciclopirox) [prescribing information]. Bridgewater, NJ: Bausch Health US LLC; May 2019.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Loprox.1">
<a name="Loprox.1"></a>Loprox Topical Suspension (ciclopirox) [prescribing information]. Fairfield, NJ: Medimetriks Pharmaceuticals Inc; March 2016.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Penlac.1">
<a name="Penlac.1"></a>Penlac Nail Lacquer Solution (ciclopirox) [prescribing information]. Bridgewater, NJ: Valeant Pharmaceuticals; June 2016.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Manu.1">
<a name="Manu.1"></a>Refer to manufacturer's labeling.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19188870">
<a name="19188870"></a>Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. <i>Pediatr Crit Care Med</i>. 2009;10(2):256-259. doi:10.1097/PCC.0b013e31819a383c<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/ciclopirox-pediatric-drug-information/abstract-text/19188870/pubmed" id="19188870" target="_blank">19188870</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25294700">
<a name="25294700"></a>van Zuuren EJ, Fedorowicz Z, El-Gohary M. Evidence-based topical treatments for tinea cruris and tinea corporis: a summary of a Cochrane systematic review. <i>Br J Dermatol</i>. 2015;172(3):616-641. doi:10.1111/bjd.13441<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/ciclopirox-pediatric-drug-information/abstract-text/25294700/pubmed" id="25294700" target="_blank">25294700</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12046779">
<a name="12046779"></a>Weinstein A, Berman B. Topical treatment of common superficial tinea infections. <i>Am Fam Physician</i>. 2002;65(10):2095-2102.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/ciclopirox-pediatric-drug-information/abstract-text/12046779/pubmed" id="12046779" target="_blank">12046779</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 13063 Version 302.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
